SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-008451
Filing Date
2023-11-14
Accepted
2023-11-14 16:22:24
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 1729117
2 CERTIFICATION vnrx_ex311.htm EX-31.1 11747
3 CERTIFICATION vnrx_ex312.htm EX-31.2 9882
4 CERTIFICATION vnrx_ex321.htm EX-32.1 4850
  Complete submission text file 0001477932-23-008451.txt   8174246

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20230930.xsd EX-101.SCH 93535
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20230930_lab.xml EX-101.LAB 432499
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20230930_cal.xml EX-101.CAL 55061
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20230930_pre.xml EX-101.PRE 382620
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20230930_def.xml EX-101.DEF 268806
65 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 1577393
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 231406742
SIC: 2835 In Vitro & In Vivo Diagnostic Substances